Search results
NJ health care, pharmaceutical companies cutting jobs as tech disrupts industry
The Bergen Record via Yahoo News· 12 hours agoAnd...
Why Things Could Get Worse for Pfizer Stock Before They Get Better
Motley Fool via Yahoo Finance· 2 days agoAt the very least, investors should brace for a bumpy ride over the next six years. Pfizer plans to ...
Pfizer sees lung cancer drug topping $1 billion in sales following impressive 5-year data
FOX Business· 7 days agoPfizer said it expects its cancer drug Lorbrena to top $1 billion in annual sales by 2030 on the...
Retirement Roadblocks: 7 Stocks to Avoid as You Near the Finish Line
InvestorPlace· 4 days agoAs you approach retirement, it’s crucial to carefully consider your investment portfolio and make...
3 Discounted Stocks Poised for a Major Upswing
InvestorPlace· 5 days agoRecent financial results for the first one show robust revenue growth and enhanced gross margins, underpinned by efficient cost control. Rising revenue per user and lower ...
Sony Pictures CEO announces controversial change to films and TV shows
TheStreet.com· 3 days agoTony Vinciquerra, CEO of Sony Pictures Entertainment, just warned that the company is looking to make a major cost-cutting move.
2 High-Yield Dividend ETFs to Buy to Generate Passive Income
Motley Fool via Yahoo Finance· 5 days agoDividend Equity ETF wasn’t one of them. The 10 stocks that made the cut could produce monster...
ASCO: Cautious Big Pharmas double down on past wins—steering clear of radioligands and cell therapy
FierceBiotech· 2 days agoThis year’s American Society of Clinical Oncology (ASCO) conference in Chicago marked a return to...
Here’s what a Nobel Prize-winning scientist wants you to know about the Covid-19 vaccines and the...
CNN via Yahoo News· 2 days agoIn his new book “The Catalyst,” Thomas R. Cech talks about the Covid-19 vaccines, what RNA means for...
U.S. Companies Paid a Record $164.3 Billion in Dividends in the First Quarter. Here Are 2 ETFs to...
Motley Fool via Yahoo Finance· 6 days agoThe Motley Fool recommends 3M, Amgen, Lockheed Martin, T. Rowe Price Group, and Verizon...
